Percutaneous Bone Conduction Implant Anti-Microbial Coating

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Percutaneous bone conduction implants face challenges with infection and inflammation due to bacterial colonization at the skin-implant interface, primarily caused by micro-leakage gaps between the fixture and abutment components.

Innovation Solution

The implementation of a percutaneous bone conduction implant with an anti-microbial surface coating on the fixture-abutment assembly, combined with a mechanically tight fit and surface modifications to reduce shear modulus, minimizes micro-leakage and enhances integration with surrounding tissue, thereby reducing bacterial colonization.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If a percutaneous bone conduction implant is used to transmit sound vibrations to the skull, then hearing capability is improved, but the risk of infection and inflammation increases due to bacterial colonization at the skin-implant interface

Engineering Contradiction:
Improvehearing capabilityVSAvoidinfection and inflammation
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent applies preliminary anti-action by incorporating an anti-microbial coating on the fixture and abutment surfaces before implantation. This coating proactively prevents bacterial colonization at the skin-implant interface, addressing the infection risk before it can occur during the healing period.

Inventive Principle:
Principle #9Preliminary anti-action

Solution Approach 2:

The anti-microbial coating acts as an intermediary layer between the implant surfaces and the surrounding biological environment. This intermediate layer specifically targets and neutralizes bacterial colonization while allowing the implant to maintain its mechanical function and integration with bone and skin tissues.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Object-affected harmful factors

If the fixture and abutment are connected to form a sealed assembly, then bacterial colonization is reduced, but manufacturing precision requirements increase to minimize micro-leakage gaps

Engineering Contradiction:
Improvebacterial colonizationVSAvoidmicro-leakage gaps
Core Design Contradiction:
Object-affected harmful factorsVSManufacturing precision

Solution Approach 1:

The anti-microbial coating provides preliminary protection that compensates for potential micro-leakage gaps. Even if small gaps exist between the fixture and abutment, the coating on these surfaces prevents bacterial penetration through the gaps, reducing the stringency of manufacturing precision requirements.

Inventive Principle:
Principle #9Preliminary anti-action

Solution Approach 2:

The patent changes the surface properties of the fixture and abutment by applying an anti-microbial coating. This parameter change modifies the surface characteristics to be bacteria-resistant, which allows for more tolerant manufacturing tolerances while maintaining the sealed environment necessary to prevent infection.

Inventive Principle:
Principle #35Parameter changes

3Object-affected harmful factors

If the anti-microbial coating is applied to interior surfaces of the fixture-abutment assembly, then bacterial growth is minimized, but the coating may degrade if exposed to the surrounding environment

Engineering Contradiction:
Improvebacterial growthVSAvoidcoating potency
Core Design Contradiction:
Object-affected harmful factorsVSDuration of action of stationary object

Solution Approach 1:

The anti-microbial coating is selectively applied to specific interior surfaces of the fixture and abutment where bacterial contact is most likely to occur. This localized application ensures maximum protection at critical interfaces while minimizing the total coating surface area exposed to degrading environmental factors.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The coating serves as a protective intermediary layer on interior surfaces that are potentially exposed to the surrounding environment. This intermediary layer prevents direct contact between environmental degradation factors and the coating, thereby maintaining coating potency over the implant's service life.

Inventive Principle:
Principle #24Intermediary (Mediator)

Data Source

PatentUS8787607B2Percutaneous bone conduction implant
Publication Date: 2014.07.22 COCHLEAR LIMITED
  • US8787607B2 patent drawing
  • US8787607B2 patent drawing
  • US8787607B2 patent drawing

AI summary

One embodiment relates to a percutaneous bone conduction implant. The implant includes a fixture configured to be anchored in the recipient's skull, and a skin-penetrating abutment configured to interface with the fixture and to permit the abutment to be removably attached to the fixture to form a fixture-abutment assembly. In an embodiment, at least one anti-microbial surface forms one or more surfaces of the formed fixture-abutment assembly located in an interior of the formed fixture-abutment assembly when the fixture is removably attached to the abutment with an abutment screw. The interior is substantially isolated from a surrounding environment of the fixture-abutment assembly.